NCT07422298PHASE1RecruitingAccepts Healthy Volunteers

A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants

Bristol-Myers Squibb

Start Date

2/19/2026

Completion Date

6/15/2026

Summary

The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.

Eligibility Criteria

Age Range: 18 years to 55 years

Inclusion Criteria * Female individuals not of childbearing potential and males. * Healthy as determined by medical history, physical examination, vital signs, 12-lead ECG, and clinical laboratory assessments. * 18 to 55 years of age, inclusive, at the time of signing the informed consent with a BMI 18.0 to 32.0 kg/m2, inclusive. * Other protocol-defined Inclusion/Exclusion criteria apply.

Interventions

DRUG

BMS-986278

DRUG

Placebo

DRUG

Moxifloxacin

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Healthy Volunteers

Locations

Worldwide Clinical Trials

San Antonio, Texas 78217

United States

Run studies, or work at a research site?

Corterve helps sites and sponsors reach patients who are looking for trials. It does not determine eligibility and does not promise an enrolment outcome.

For sponsors, CROs and sites

What Corterve sells to organisations, and the anti-kickback constraints it works within.

Services and published prices

Lay summaries for EU CTR Annex V, pre-screen filtration, recruitment-creative regulatory operations, feasibility reporting.

For research sites

One published licence rate, the same for every site, and the fees a site is never charged.